Gene: APOL3
Official Full Name: apolipoprotein L3provided by HGNC
Gene Summary: This gene is a member of the apolipoprotein L gene family, and it is present in a cluster with other family members on chromosome 22. The encoded protein is found in the cytoplasm, where it may affect the movement of lipids, including cholesterol, and/or allow the binding of lipids to organelles. In addition, expression of this gene is up-regulated by tumor necrosis factor-alpha in endothelial cells lining the normal and atherosclerotic iliac artery and aorta. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2015]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04469 | APOL3 Knockout cell line (HeLa) | Human | APOL3 | 1:3~1:6 | Negative | Online Inquiry |
APOL3 Gene Knockout Cell Lines are advanced, genetically modified cell lines designed to facilitate research into the biological functions and mechanisms associated with the apolipoprotein L (APOL) gene family, particularly the APOL3 variant. These cell lines feature a targeted knockout of the APOL3 gene, which allows researchers to assess the impact of its loss on cellular pathways, disease processes, and potential therapeutic targets. The key function of these cell lines lies in their ability to provide a controlled environment to study the specific role of APOL3 in various biological contexts, including lipid metabolism, immune response, and infectious disease susceptibility.
In terms of mechanisms, APOL3 has been implicated in the regulation of cellular cholesterol levels and defense against pathogens. By employing knockout cell lines, researchers can elucidate how APOL3 interacts with cellular receptors and downstream signaling pathways, revealing insights vital for understanding diseases such as atherosclerosis and infections caused by parasites. This capability is particularly important in research settings focused on human health, where the role of specific genes in disease development needs to be clarified.
The scientific importance of APOL3 Gene Knockout Cell Lines extends to their application in drug discovery and therapeutic development, enabling the identification of novel targets for intervention. Compared to traditional cell lines, these knockout models offer a more precise approach, as they minimize genetic variability and allow for focused studies on the effects of gene knockouts, providing clearer interpretations of experimental outcomes.
One of the unique selling points of APOL3 Gene Knockout Cell Lines is their specificity; unlike other gene-editing approaches that may result in off-target effects, these lines are rigorously validated to ensure the fidelity of the knockout. This offers researchers increased confidence in their experimental results, leading to more robust conclusions and advancements in their respective fields.
Overall, the unique capabilities of APOL3 Gene Knockout Cell Lines make them an invaluable resource for researchers and clinicians committed to unraveling the complexities of gene function and its implications for human health. Our company, with extensive expertise in genetic engineering and cell line development, is proud to offer these state-of-the-art tools that empower scientists to push the boundaries of discovery in molecular biology and medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.